Invesco’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-55,011
| Closed | -$4.39M | – | 4100 |
|
|
2021
Q1 | $4.39M | Buy |
55,011
+7,549
| +16% | +$590K | ﹤0.01% | 2432 |
|
|
2020
Q4 | $3.74M | Buy |
47,462
+3,317
| +8% | +$195K | ﹤0.01% | 2325 |
|
|
2020
Q3 | $1.94M | Sell |
44,145
-4,357
| -9% | -$215K | ﹤0.01% | 2512 |
|
|
2020
Q2 | $2.15M | Sell |
48,502
-7,854
| -14% | -$293K | ﹤0.01% | 2447 |
|
|
2020
Q1 | $2.02M | Buy |
56,356
+27,917
| +98% | +$1.59M | ﹤0.01% | 2391 |
|
|
2019
Q4 | $2.02M | Sell |
28,439
-1,132
| -4% | -$82.1K | ﹤0.01% | 2640 |
|
|
2019
Q3 | $2.21M | Sell |
29,571
-2,806
| -9% | -$238K | ﹤0.01% | 2582 |
|
|
2019
Q2 | $2.61M | Sell |
32,377
-33,001
| -50% | -$2.32M | ﹤0.01% | 2559 |
|
|
2019
Q1 | $4.37M | Sell |
65,378
-512,533
| -89% | -$38.8M | ﹤0.01% | 2092 |
|
|
2018
Q4 | $43M | Sell |
577,911
-42,241
| -7% | -$3.49M | 0.02% | 831 |
|
|
2018
Q3 | $57.1M | Sell |
620,152
-213,896
| -26% | -$20.4M | 0.02% | 812 |
|
|
2018
Q2 | $82M | Buy |
834,048
+192,117
| +30% | +$21.5M | 0.03% | 625 |
|
|
2018
Q1 | $71.5M | Sell |
641,931
-11,774
| -2% | -$1.32M | 0.03% | 591 |
|
|
2017
Q4 | $67.2M | Sell |
653,705
-171,632
| -21% | -$17.1M | 0.02% | 626 |
|
|
2017
Q3 | $77.7M | Sell |
825,337
-172,284
| -17% | -$13.6M | 0.03% | 592 |
|
|
2017
Q2 | $77.7M | Buy |
997,621
+151,114
| +18% | +$11.3M | 0.02% | 589 |
|
|
2017
Q1 | $67.8M | Buy |
846,507
+2,210
| +0.3% | +$176K | 0.02% | 635 |
|
|
2016
Q4 | $66.5M | Buy |
844,297
+11,305
| +1% | +$878K | 0.02% | 665 |
|
|
2016
Q3 | $65M | Buy |
832,992
+16,107
| +2% | +$1.17M | 0.02% | 655 |
|
|
2016
Q2 | $56.1M | Buy |
816,885
+13,322
| +2% | +$919K | 0.02% | 708 |
|
|
2016
Q1 | $57.3M | Buy |
803,563
+532,782
| +197% | +$33.4M | 0.02% | 676 |
|
|
2015
Q4 | $16.8M | Buy |
270,781
+11,381
| +4% | +$694K | 0.01% | 1231 |
|
|
2015
Q3 | $14.7M | Buy |
259,400
+43,931
| +20% | +$2.33M | 0.01% | 1278 |
|
|
2015
Q2 | $11.6M | Buy |
215,469
+48,419
| +29% | +$2.36M | ﹤0.01% | 1480 |
|
|
2015
Q1 | $7.93M | Buy |
167,050
+24,509
| +17% | +$1.08M | ﹤0.01% | 1668 |
|
|
2014
Q4 | $6.17M | Sell |
142,541
-19,724
| -12% | -$806K | ﹤0.01% | 1776 |
|
|
2014
Q3 | $5.58M | Sell |
162,265
-9,659
| -6% | -$341K | ﹤0.01% | 1857 |
|
|
2014
Q2 | $6.3M | Sell |
171,924
-25,681
| -13% | -$871K | ﹤0.01% | 1805 |
|
|
2014
Q1 | $6.66M | Buy |
197,605
+1,180
| +0.6% | +$38.9K | ﹤0.01% | 1745 |
|
|
2013
Q4 | $6.66M | Buy |
196,425
+24,037
| +14% | +$833K | ﹤0.01% | 1805 |
|
|
2013
Q3 | $5.49M | Buy |
172,388
+80,940
| +89% | +$2.15M | ﹤0.01% | 1853 |
|
|
2013
Q2 | $2.06M | Buy |
+91,448
| New | +$1.98M | ﹤0.01% | 2370 |
|
Invesco's CMD Position: Q2 2021 in Review
Invesco sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 55,011 shares — an estimated $4.39M sold.
Invesco first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $82M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Invesco reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Invesco sold 55,011 Cantel Medical Corporation shares in Q2 2021, an estimated $4.39M.
- Invesco first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Invesco's Cantel Medical Corporation position peaked at $82M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.